Skip to content Skip to sidebar Skip to footer

Healthcare Stocks

Atriva Therapeutics – a new take on influenza antivirals

In September 2023 a privately held German drug development company called Atriva Therapeutics announced that it was going to go public via a reverse takeover of Biocure T echnology . That company, whose stock is traded on the Canadian Securities Exchange (CSE: CURE), will now…

ByNick SundichNovember 20, 2023

Intеgral Diagnostics experienced a sudden 25% sharе pricе dip last week: What should Investors make of it?

Intеgral Diagnostics (ASX: IDX) has recently еxpеriеncеd a significant dip in its sharе pricе, dropping by over 25% on last Friday (November 3). This downturn is attributed to the company's latеst opеrating updatе, which reveals struggles with inflation and an inability to kееp pacе with it. Integral Diagnostics (ASX:IDX) share price chart, log scale (Source: TradingView) Who…

ByUjjwal MaheshwariNovember 10, 2023

Ozempic: Here’s why 2023’s star obesity treatment is causing headaches for CSL and several other biotech stocks

Ozempic is one of the few things giving CSL (ASX:CSL) shareholders sleepless nights right now. And you could argue this weight-loss drug is also having an impact on all biotech stocks. Because if you get rid of obesity, you might get rid of a lot of health problems that other biotech and medtech stocks are dealing…

ByNick SundichOctober 19, 2023

FDA approval: Here’s how ASX biotechs and medtechs obtain it

Last week one of our favourite companies Cyclopharm (ASX:CYC) obtained FDA approval, a goal it had been striving for years to obtain and one that wasn't reached without setbacks along the way. Many of our readers have asked about how FDA approval works and so we thought we would outline how this happens. For clarification, we are…

ByNick SundichOctober 9, 2023

The 3 best ASX biotech stocks for September!

Here are a trio of companies that we think are the best ASX biotech stocks for September! What are the Best stocks to invest in right now? Check our buy/sell stock tips The 3 best ASX biotech stocks for September! 1. Cyclopharm (ASX:CYC) As a stock that is in our view one of the top…

ByNick SundichSeptember 6, 2023

Are healthcare stocks defensive? Here’s 4 reasons we think they are

Why are healthcare stocks defensive? This question starts with a perception that healthcare stocks are defensive and it begs its own question - is this even true? In our view, many healthcare stocks can be defensive, but not all of them are. And there are risks that come with these companies, but not with any others. Why…

ByNick SundichSeptember 4, 2023

Healthia (ASX:HLA) is not sexy, but could deliver some dazzling returns in FY24

Each week at Stocks Down Under, we write one in-depth article about a particular company we like and this week it is Healthia (ASX:HLA). Healthia is one of those companies that has been sold off because of short-term issues that don't impact the long-term demand. But when will it turn around? Do you need solid trading & investment…

ByNick SundichMay 16, 2023

the Kick-ass Multipurpose WordPress Theme

Healthcare Stocks

Atriva Therapeutics – a new take on influenza antivirals

Intеgral Diagnostics experienced a sudden 25% sharе pricе dip last week: What should Investors make of it?

Ozempic: Here’s why 2023’s star obesity treatment is causing headaches for CSL and several other biotech stocks

FDA approval: Here’s how ASX biotechs and medtechs obtain it

The 3 best ASX biotech stocks for September!

Are healthcare stocks defensive? Here’s 4 reasons we think they are

Healthia (ASX:HLA) is not sexy, but could deliver some dazzling returns in FY24

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Healthcare Stocks

Add Your Heading Text Here